FDA Inspection 1115588 — Hakim Charfi
The FDA completed an inspection of Hakim Charfi on Dec 13, 2019 in Rennes Cedex. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Dec 13, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rennes Cedex (France)
Additional Details
Clinical BA/BE